ANPEP and cancer: We hypothesized that specific PMT/PDMTs produced by cancer cells may silence the transcription of effector T-cell chemokines or HLA class I and APM components, leading to decreased effector T-cell trafficking and/or reduced antigen presentation in SCCHN.